Correlation Between Krystal Biotech and Charles River

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Krystal Biotech and Charles River at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krystal Biotech and Charles River into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krystal Biotech and Charles River Laboratories, you can compare the effects of market volatilities on Krystal Biotech and Charles River and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krystal Biotech with a short position of Charles River. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krystal Biotech and Charles River.

Diversification Opportunities for Krystal Biotech and Charles River

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Krystal and Charles is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Krystal Biotech and Charles River Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Charles River Labora and Krystal Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krystal Biotech are associated (or correlated) with Charles River. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Charles River Labora has no effect on the direction of Krystal Biotech i.e., Krystal Biotech and Charles River go up and down completely randomly.

Pair Corralation between Krystal Biotech and Charles River

Given the investment horizon of 90 days Krystal Biotech is expected to generate 1.53 times more return on investment than Charles River. However, Krystal Biotech is 1.53 times more volatile than Charles River Laboratories. It trades about 0.06 of its potential returns per unit of risk. Charles River Laboratories is currently generating about -0.02 per unit of risk. If you would invest  7,756  in Krystal Biotech on November 9, 2024 and sell it today you would earn a total of  8,350  from holding Krystal Biotech or generate 107.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Krystal Biotech  vs.  Charles River Laboratories

 Performance 
       Timeline  
Krystal Biotech 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Krystal Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Charles River Labora 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Charles River Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in March 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Krystal Biotech and Charles River Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Krystal Biotech and Charles River

The main advantage of trading using opposite Krystal Biotech and Charles River positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krystal Biotech position performs unexpectedly, Charles River can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Charles River will offset losses from the drop in Charles River's long position.
The idea behind Krystal Biotech and Charles River Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon